Izraelis - hebrajų - Ministry of Health

gilead sciences israel ltd - amphotericin b - אבקה להכנת תרכיז לאינפוזיה - amphotericin b 50 mg/vial - amphotericin b - amphotericin b - antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin b in effective dosages. this drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with aids or cancer). ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. hiv positive). empirical treatment of presumed fungal infection in febrile neutropenic patients.

Izraelis - hebrajų - Ministry of Health

gilead sciences israel ltd - amphotericin b - אבקה להכנת תרכיז לאינפוזיה - amphotericin b 50 mg/vial - amphotericin b

Izraelis - hebrajų - Ministry of Health

gilead sciences israel ltd - amphotericin b - אבקה להכנת תרכיז לאינפוזיה - amphotericin b 50 mg/vial - amphotericin b

Izraelis - hebrajų - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

Izraelis - hebrajų - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

Izraelis - hebrajų - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - posaconazole 100 mg - posaconazole

Izraelis - hebrajų - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרכיז להכנת תמיסה לאינפוזיה - posaconazole 300 mg/vial - posaconazole

Izraelis - hebrajų - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - קפסולה קשיחה - isavuconazole as sulfate 100 mg - isavuconazole

Izraelis - hebrajų - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - אבקה להכנת תמיסה מרוכזת לעירוי - isavuconazole as sulfate 200 mg - isavuconazole

Izraelis - hebrajų - Ministry of Health

merck sharp & dohme israel ltd - caspofungin as acetate - אבקה להכנת תמיסה מרוכזת לעירוי - caspofungin as acetate 50 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.